Martin, drugs for male GU Flashcards
What drugs are used for BPH
5a-reductase inhibitors
alpha adrenergic antagonists
saw palmetto
what drugs are used for ED
PDE 5 inhibitors
alprostadil
what are the 5alpha reductase inhibitors
finasteride and durasteride
what are the alpha adrenergic antagonists
prozosin terzosin doxazosin alfuzosin tamsulosin silodosin
what are the PDE 5 inhibitors
sildenafil(viagra)
tadalafil
vardenafil
avanafil
MOA 5 alpha reductase inhibitor
inhibition 5a reductase reduces levels of dihydrotestosterone within 8 hours
adverse effects 5 alpha reductase inhibitors
impotence and decreased libido
which 5 alpha reductase inhibitor preferentially antagonizes type II 5 alpha reductase
finasteride
finasteride also approved to Tx what
male pattern baldness
hirsutism in women
what drug has a longer half life than finasteride
dutasteride
clinical manifestations of BPH
increased frequency of urination, nocturia, hesitancy, urgency and weak urinary system
when does tx start for BPH
Sx have significant impact on patients life
alpha adrenergic antagonists are used to Tx what
pheochromocytoma, primary HTN, BPH, Ischemic HD, arrhythmias, endocrinologic and neurologic disorders and glaucoma
most common cause ED
atherosclerosis
what R mediate smooth muscle tone in prostate
alpha 1
what are the long acting alpha adrenergic antagonists
everyone EXCEPT prazosin
which alpha antagonist has more CV side effects
prazosin
adverse effects prazosin
palpitations and orthostatic hypotension/syncope
common drugs that alter sexual response
SSRIs antidepressants spironolactone and thiazide diuretics antipsychotics-phenothiazines benzodiazepines, alcohol, cocaine, marijuana, hallucinogens nonselective beta blockers centrally-acting sympatholytics
which alpha antagonist is selcetive for a1A and a1D
tamsulosin
adverse effect tamsulosin
abnormal ejaculation
MOA saw palmeto
inhibits 5 alpha reductase I and II and inhibits dihydrotestosterone binding to androgen R
saw palmetto is better for what stage BPH
mild to moderate
MOA PDE 5 inhibitors
selective inhibition of PDE-5 increase intracavernosal cGMP levels and causes relaxation of the nonvascular smooth muscle of corpora cavernosa